8:00 a.m. – 10:00 a.m.

EDRN Collaborative Group Meetings

8:00 a.m. – 10:00 a.m.

Breast/Gynecological Cancers

8:00 a.m. – 10:00 a.m.

Gastrointestinal Cancers

8:00 a.m. – 10:00 a.m.

Lung/Upper Aerodigestive Cancers

8:00 a.m. – 10:00 a.m.

Prostate/Genitourinary Cancers

10:00 a.m. – 10:15 a.m.

Break

10:15 a.m. - 12:05 p.m.

Main 41st EDRN Steering Committee Meeting

10:15 a.m. – 10:25 a.m.

01: Status of the EDRN

(In-person) Sudhir Srivastava, PhD, MPH, National Cancer Institute

10:25 a.m. – 10;30 a.m.

Q&A

10:30 a.m. – 11:00 a.m.

Data Sharing and Bioinformatics

10:30 a.m. – 10:45 a.m.

02: Overview

(In-person) Daniel Crichton, MS, NASA Jet Propulsion Laboratory

10:45 a.m. – 11:00 a.m.

Panel Discussion

• (In-person) Dan Crichton, MS, Jet Propulsion Laboratory
• (In-person) Jennifer Beane, PhD, Boston University
• (In-person) Ashish Mahabal, PhD, Caltech
• (Virtual) Amanda Skarlupka, PhD, National Cancer Institute
• (Virtual) Natalie Abrams, PhD, National Cancer Institute

11:00 a.m. – 11:30 a.m.

Access to EDRN Biospecimens

11:00 a.m. – 11:15 a.m.

03: Overview

(In-person) Robert Bresalier, MD, The University of Texas MD Anderson Cancer Center

11:15 a.m. – 11:30 a.m.

Panel Discussion

• (In-person) Stephen Deppen, PhD, Vanderbilt University Medical Center
• (In-person) Karen Anderson, MD, PhD, Arizona State University
• (In-person) Ziding Feng, PhD, Fred Hutchinson Cancer Center
• (In-person) Matt Young, PhD, National Cancer Institute

11:30 a.m. – 12:00 p.m.

Update on Clinical Utility Trials

11:30 a.m. – 11:45 a.m.

04: National Liver Cancer Screening Trial (TRACER)

(In-person) Amit Singal, MD, The University of Texas Southwestern Medical Center

11:45 a.m. – 12:00 p.m.

05: Lung

(In-person) James Herman, MD, University of Pittsburgh School of Medicine

12:00 p.m. – 12:05 p.m.

Closing Remarks

(In-person) Sudhir Srivastava, PhD, MPH, National Cancer Institute

12:05 p.m.

Adjourn